These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2022 related items for PubMed ID: 14551031

  • 1. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
    Guo L, Fujino M, Kimura H, Funeshima N, Kitazawa Y, Harihara Y, Tezuka K, Makuuchi M, Suzuki S, Li XK.
    Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031
    [Abstract] [Full Text] [Related]

  • 2. AdCTLA-4Ig combined with donor splenocytes, bone marrow cells and anti-ICOS antibody treatment induce tolerance in a rat heart transplantation model.
    Guo L, Fujino M, Kimura H, Funeshima N, Kitazawa Y, Harihara Y, Tezuka K, Makuuchi M, Suzuki S, Li XK.
    Transpl Int; 2004 Jan; 17(1):15-21. PubMed ID: 12942167
    [Abstract] [Full Text] [Related]

  • 3. Further study of anti-ICOS immunotherapy for rat cardiac allograft rejection.
    Pan XC, Guo L, Deng YB, Naruse K, Kimura H, Sugawara Y, Makuuchi M.
    Surg Today; 2008 Jan; 38(9):815-25. PubMed ID: 18751947
    [Abstract] [Full Text] [Related]

  • 4. Anergic lymphocytes generated by blocking CD28 and ICOS pathways in vitro prolong rat cardiac graft survival.
    Hara Y, Kitazawa Y, Funeshima N, Kawasaki M, Sato Y, Tezuka K, Kimura H, Hatakeyama K, Li XK.
    Int Immunopharmacol; 2006 Jul; 6(7):1143-51. PubMed ID: 16714218
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
    Guillonneau C, Aubry V, Renaudin K, Séveno C, Usal C, Tezuka K, Anegon I.
    Transplantation; 2005 Aug 27; 80(4):546-54. PubMed ID: 16220623
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Simultaneous blockade of costimulatory signals CD28-CD80 and CD40-CD154 combined with monoclonal antibody against CD25 induced a stable chimerism and tolerance without graft-versus-host disease in rat.
    Zhu ZX, Fan LY, Wang Q.
    Eur Surg Res; 2011 Aug 27; 46(3):109-17. PubMed ID: 21242693
    [Abstract] [Full Text] [Related]

  • 9. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.
    Otomo N, Margenthaler JA, Motoyama K, Arima T, Shimizu Y, Lehmann M, Flye MW.
    J Surg Res; 2001 Jun 01; 98(1):59-65. PubMed ID: 11368539
    [Abstract] [Full Text] [Related]

  • 10. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
    Pu LY, Wang XH, Zhang F, Li XC, Yao AH, Yu Y, Lv L, Li GQ.
    Surgery; 2007 Jul 01; 142(1):67-73. PubMed ID: 17630002
    [Abstract] [Full Text] [Related]

  • 11. Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft.
    Margenthaler JA, Yu S, Otomo N, Lehmann M, Flye MW.
    Transpl Int; 2003 Oct 01; 16(10):713-20. PubMed ID: 12827227
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
    Guillonneau C, Aubry V, Renaudin K, Séveno C, Usal C, Tezuka K, Anegon I.
    Transplantation; 2005 Jul 27; 80(2):255-63. PubMed ID: 16041272
    [Abstract] [Full Text] [Related]

  • 13. Injection of donor-derived OX62+ splenic dendritic cells with anti-CD4 monoclonal antibody generates CD4+CD25+FOXP3+ regulatory T cells that prolong allograft skin survival indefinitely and abrogate production of donor-specific antibodies in a rat model.
    Alawieh M, Rifle G, Bouchot O, Malapert G, Mousson C, Martin L.
    Transplant Proc; 2009 Oct 27; 41(8):3363-6. PubMed ID: 19857750
    [Abstract] [Full Text] [Related]

  • 14. Tolerance induction to cardiac allografts by simultaneous or sequential intrathymic inoculation of disparate alloantigens.
    Shimomura K, Hardy MA, Oluwole SF.
    Transplantation; 1995 Oct 27; 60(8):806-11. PubMed ID: 7482739
    [Abstract] [Full Text] [Related]

  • 15. Adoptive transfer of transplantation tolerance mediated by CD4+CD25+ and CD8+CD28- regulatory T cells induced by anti-donor-specific T-cell vaccination.
    Wang J, Zhang L, Tang J, Jiang S, Wang X.
    Transplant Proc; 2008 Jun 27; 40(5):1612-7. PubMed ID: 18589160
    [Abstract] [Full Text] [Related]

  • 16. Long-term acceptance of rat cardiac allografts on the basis of adenovirus mediated CD40Ig plus CTLA4Ig gene therapies.
    Yamashita K, Masunaga T, Yanagida N, Takehara M, Hashimoto T, Kobayashi T, Echizenya H, Hua N, Fujita M, Murakami M, Furukawa H, Uede T, Todo S.
    Transplantation; 2003 Oct 15; 76(7):1089-96. PubMed ID: 14557758
    [Abstract] [Full Text] [Related]

  • 17. Induction of regulatory cells and control of cellular but not vascular rejection by costimulation blockade in hamster-to-rat heart xenotransplantation.
    Séveno C, Coulon F, Haspot F, Mérieau E, Renaudin K, Martinet B, Vanhove B.
    Xenotransplantation; 2007 Jan 15; 14(1):25-33. PubMed ID: 17214702
    [Abstract] [Full Text] [Related]

  • 18. Induction of "infectious" tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients.
    Onodera K, Lehmann M, Akalin E, Volk HD, Sayegh MH, Kupiec-Weglinski JW.
    J Immunol; 1996 Sep 01; 157(5):1944-50. PubMed ID: 8757313
    [Abstract] [Full Text] [Related]

  • 19. Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival.
    Comer RM, King WJ, Ardjomand N, Theoharis S, George AJ, Larkin DF.
    Invest Ophthalmol Vis Sci; 2002 Apr 01; 43(4):1095-103. PubMed ID: 11923251
    [Abstract] [Full Text] [Related]

  • 20. CD25+CD4+ regulatory T cells develop in mice not only during spontaneous acceptance of liver allografts but also after acute allograft rejection.
    Steger U, Kingsley CI, Karim M, Bushell AR, Wood KJ.
    Transplantation; 2006 Nov 15; 82(9):1202-9. PubMed ID: 17102772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 102.